Inspire Medical Systems, Inc. to Report Third Quarter 2025 Financial Results on November 3, 2025

Core Viewpoint - Inspire Medical Systems, Inc. is set to release its financial results for Q3 2025 on November 3, 2025, followed by a conference call to discuss these results and recent business developments [1]. Financial Results Announcement - The financial results for the third quarter of 2025 will be released after the close of trading on November 3 [1]. - A conference call will be hosted by Inspire's management team at 5:00 p.m. Eastern Time on the same day to discuss the results [1]. Webcast and Participation - A webcast of the conference call will be available on the Investor Relations page of Inspire's website [2]. - For those wishing to ask questions, registration is required, and an email will be sent with dial-in details and a unique access code [3]. - The company recommends registering at least 10 minutes before the call to ensure connection [3]. Replay Availability - A replay of the conference call will be accessible on the Investor Relations website approximately two hours after the event and will be archived for two weeks [4]. Company Overview - Inspire Medical Systems focuses on developing and commercializing innovative, minimally invasive solutions for patients with obstructive sleep apnea [5]. - The company's proprietary Inspire therapy is the first and only FDA, EU MDR, and PDMA-approved neurostimulation technology for treating moderate to severe obstructive sleep apnea [5].